简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2019-09-20 09:26 Consistent cardiovascular benefits shown with empagliflozin treatment regardless of the number of controlled cardiovascular risk factors
2019-09-19 19:27 Solasia Announces Patient Registration Reached Target Number of Cases for Darinaparsin Phase 2 Pivotal Study for T-Cell Lymphoma
2019-09-19 15:51 CORRECTING and REPLACING Three Hospital Systems Earn Five-Star Award from Patient Safety Movement Foundation
2019-09-19 12:44 Shiseido Marks the 30th Anniversary of Joint Research in Dermatology
2019-09-19 09:32 Bayer Selects Savonix Digital Cognitive Assessment Platform to Validate the Effects of Multivitamin Supplement Berocca in Malaysia
2019-09-18 17:17 Daon Announces John Sanders as President of Emerging Markets
2019-09-17 18:40 PSE plans to become part of Siemens
2019-09-16 10:40 Flight Aid, a Product to Support the Pressure Release Felt in the Ears Invented by a Dentist Based on 40 Years of Clinical Experience Using the 2MC Method Will Be Launched on the Market on September 16, 2019
2019-09-12 16:49 Hansoh Pharma and Atomwise Launch Strategic AI Drug Discovery Collaboration for Multiple Therapeutic Areas
2019-09-12 15:50 Retail Giant and CE China Partner Suning to Showcase Biu+ Smart Home Solution at CE China
2019-09-12 14:50 HemoSonics Registers CE Mark for its New QStat® Cartridge, Expanding the Use of its Innovative Quantra® Hemostasis System to Trauma Surgery and Liver Transplant Settings
2019-09-12 11:39 ABEC Sets Benchmark in Productivity for Flexible Biopharmaceutical Manufacturing
2019-09-12 11:34 ABEC Advances Single-Use Bioreactor Volumes to 6,000 Liters
2019-09-11 15:57 Opentrons Launches The World’s Most Fully Affordable Thermocycler
2019-09-11 14:32 NIAS Testing: Protecting Food Safety for Consumers
2019-09-11 10:06 Clover Biopharmaceuticals Doses First Patient in Phase I Study of SCB-313 in China for Peritoneal Carcinomatosis
2019-09-11 10:05 Samsung Bioepis Continues Global Expansion, Enters Brazilian Biopharmaceutical Market with BRENZYS™ (etanercept)
2019-09-10 13:47 Aptorum Group Announces the Development of Microbiome Drug Candidate Targeting Obesity and Repurposed Drug Candidates Targeting Neuroblastoma
2019-09-10 10:22 Aptorum Group Has Initiated IND-Enabling Studies For Its ALS-4 Small Molecule Candidate For The Treatment Of Infections Caused By Staphylococcus Aureus Including MRSA
2019-09-10 09:35 Data from Ozanimod Clinical Development Program in Relapsing Forms of Multiple Sclerosis to Be Presented at the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis

Business Wire Weibo

Press Releases

Latest Releases